Teva Completes Acquisition of Emalex Biosciences
Teva has completed its acquisition of Emalex Biosciences, strengthening its late-stage neuroscience pipeline. The deal supports Teva’s Pivot to Growth strategy.
Neuroscience Pipeline | 12/06/2026 | By News Bureau | 140
Lilly to Acquire Centessa in USD 6.3 Billion Deal, Expands Neuroscience Pipeline
Eli Lilly and Company has announced a definitive agreement to acquire Centessa Pharmaceuticals plc, strengthening its neuroscience portfolio and advancing next-generation therapies for sleep-related and neurological disorders.
Neuroscience Pipeline | 01/04/2026 | By Darshana | 143
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy